Precision medicine has attracted a lot of attention in the healthcare industry over the past several months, particularly since President Obama announced the administration's Precision Medicine Initiative (PMI) in January. While the term can be open to broad interpretation, most companies and other stakeholders seem to agree that the one-size-fits-all treatment approach is not good enough.